Education
About Us
Working with TipRanks
Follow Us
GlaxoSmithKline (GB:GSK)
LSE:GSK
Total Valuation
GlaxoSmithKline has a market cap or net worth of £88.73B. The enterprise value is 103.11B.
Market Cap£88.73B
Enterprise Value103.11B
Share Statistics
GlaxoSmithKline has 4,073,100,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,073,100,300
Owned by Insiders1.12%
Owned by Institutions0.07%
Financial Efficiency
GlaxoSmithKline’s return on equity (ROE) is 0.35 and return on invested capital (ROIC) is 14.25%.
Return on Equity (ROE)0.35
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)14.25%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee475.99K
Profits Per Employee83.29K
Employee Count68,629
Asset Turnover0.53
Inventory Turnover1.51
Valuation Ratios
The current PE Ratio of GlaxoSmithKline is 15.6. GlaxoSmithKline’s PEG ratio is 0.10.
PE Ratio15.6
PS Ratio2.26
PB Ratio4.51
Price to Fair Value4.51
Price to FCF12.41
Price to Operating Cash Flow11.71
PEG Ratio0.10
Income Statement
In the last 12 months, GlaxoSmithKline had revenue of 32.67B and earned 5.72B in profits. Earnings per share was 1.41.
Revenue32.67B
Gross Profit23.70B
Operating Income7.17B
Pretax Income7.40B
Net Income5.72B
EBITDA11.88B
Earnings Per Share (EPS)1.41
Cash Flow
In the last 12 months, operating cash flow was 7.55B and capital expenditures -2.53B, giving a free cash flow of 5.02B billion.
Operating Cash Flow7.55B
Free Cash Flow5.02B
Free Cash Flow per Share1.23
Dividends & Yields
GlaxoSmithKline pays an annual dividend of 16p, resulting in a dividend yield of 3.29%
Dividend Per Share16p
Dividend Yield3.29%
Payout Ratio48.47%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.04
52-Week Price Change56.18%
50-Day Moving Average1.95K
200-Day Moving Average1.63K
Relative Strength Index (RSI)65.49
Average Volume (3m)8.54M
Important Dates
GlaxoSmithKline upcoming earnings date is Apr 29, 2026, Before Open (Confirmed).
Last Earnings DateFeb 4, 2026
Next Earnings DateApr 29, 2026
Ex-Dividend Date―
Financial Position
GlaxoSmithKline as a current ratio of 0.82, with Debt / Equity ratio of 108.20%
Current Ratio0.82
Quick Ratio0.54
Debt to Market Cap0.24
Net Debt to EBITDA1.21
Interest Coverage Ratio10.23
Taxes
In the past 12 months, GlaxoSmithKline has paid 1.11B in taxes.
Income Tax1.11B
Effective Tax Rate0.15
Enterprise Valuation
GlaxoSmithKline EV to EBITDA ratio is 7.43, with an EV/FCF ratio of 14.82.
EV to Sales2.70
EV to EBITDA7.43
EV to Free Cash Flow14.82
EV to Operating Cash Flow12.08
Balance Sheet
GlaxoSmithKline has £3.41B in cash and marketable securities with £17.72B in debt, giving a net cash position of -£14.31B billion.
Cash & Marketable Securities£3.41B
Total Debt£17.72B
Net Cash-£14.31B
Net Cash Per Share-£3.51
Tangible Book Value Per Share-£1.91
Margins
Gross margin is 72.49%, with operating margin of 21.95%, and net profit margin of 17.50%.
Gross Margin72.49%
Operating Margin21.95%
Pretax Margin22.66%
Net Profit Margin17.50%
EBITDA Margin36.38%
EBIT Margin24.81%
Analyst Forecast
The average price target for GlaxoSmithKline is £1,988.57, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target£1,988.57
Price Target Upside-9.65% Downside
Analyst ConsensusHold
Analyst Count15
Revenue Growth Forecast2.73%
EPS Growth Forecast119.38%